Cargando…

rHuEPO Hyporesponsiveness and Related High Dosages Are Associated with Hyperviscosity in Maintenance Hemodialysis Patients

Objective. Increased viscosity may increase the risk of thrombosis or thromboembolic events. Recombinant human erythropoietin (rHuEPO) is the key stone treatment in anemic ESRD patients with the thrombotic limiting side effect. We evaluated the influence of clinical and laboratory findings on plasma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erkmen Uyar, Mehtap, Toprak, Selami Kocak, Saglam, Hatice, Tutal, Emre, Bay, Meltem, Ilhan, Osman, Bal, Zeynep, Sezer, Siren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806397/ https://www.ncbi.nlm.nih.gov/pubmed/24198729 http://dx.doi.org/10.1155/2013/792698

Ejemplares similares

Long-Term Oral Nutrition Supplementation Improves Outcomes in Malnourished Patients With Chronic Kidney Disease on Hemodialysis
por: Sezer, Siren, et al.
Publicado: (2014)

Darbepoetin alfa is more potent in vivo and can be administered less frequently than rHuEPO
por: Egrie, J, et al.
Publicado: (2002)

A Conjugated Aptamer-Gold Nanoparticle Fluorescent Probe for Highly Sensitive Detection of rHuEPO-α
por: Sun, Jiefang, et al.
Publicado: (2011)

Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration
por: Wang, Guan, et al.
Publicado: (2017)

Clinical study of Shengxuening tablet combined with rHuEPO for the treatment of renal anemia of maintenance hemodialysis patients
por: CHENG, XIN, et al.
Publicado: (2016)

Proof-of-concept study on improved efficacy of rHuEPO administered as a long-term infusion in rats
por: Szczesny, Damian, et al.
Publicado: (2020)

New-Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients
por: Sezer, Siren, et al.
Publicado: (2015)

Factors Influencing Hemoglobin Variability and Its Association with Mortality in Hemodialysis Patients
por: Bal, Zeynep, et al.
Publicado: (2018)

Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients
por: Uyar, Mehtap Erkmen, et al.
Publicado: (2016)

Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
por: Kittur, Farooqahmed S., et al.
Publicado: (2023)

Adsorptive Leukocytapheresis in Inflammatory Bowel Diseases: Our Preliminary Results are Encouraging
por: Törüner, Murat, et al.
Publicado: (2013)

Hyperviscosity syndrome revisited
por: Gangopadhyay, Debasree, et al.
Publicado: (2022)

Is There an Optimal Timing of Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Agents?
por: Toprak, Selami Koçak
Publicado: (2013)

Past, present and future in low-risk myelodysplastic syndrome
por: Toprak, Selami Kocak
Publicado: (2022)

Comparison of preemptive kidney transplant recipients with nonpreemptive kidney recipients in single center: 5 years of follow-up
por: Sayin, Burak, et al.
Publicado: (2013)

r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
por: Tapolyai, Mihály, et al.
Publicado: (2003)

Cerebral Infarction in IgG Multiple Myeloma with Hyperviscosity
por: Park, Man-Seok, et al.
Publicado: (2005)

Hyperviscosity retinopathy as the initial presentation of aggressive multiple myeloma
por: Kuo, Hua-Hsuan, et al.
Publicado: (2020)

Lymphoid morphology, hyperviscosity and extensive immunoglobulin deposits in myeloma
por: Sehgal, Tushar, et al.
Publicado: (2022)

Blood hyperviscosity in acute and recent COVID-19 infection
por: Shaik, Aleesha, et al.
Publicado: (2022)

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)

Is there a link between hyperuricemia, morning blood pressure surge, and non-dipping blood pressure pattern in metabolic syndrome patients?
por: Tutal, Emre, et al.
Publicado: (2013)

Thrombosis and risk factors: A comment
por: Toprak, Selami Koçak, et al.
Publicado: (2012)

Total Antioxidant Capacity and Lipid Peroxidation in Semen of Patient with Hyperviscosity
por: Layali, Issa, et al.
Publicado: (2015)

Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia
por: Weaver, Allison, et al.
Publicado: (2020)

Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma
por: Ferreira Santos da Cruz, Natasha, et al.
Publicado: (2021)

Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center
por: Cengiz Seval, Guldane, et al.
Publicado: (2023)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

sEPCR Levels in Chronic Myeloproliferative Diseases and Their Association with Thromboembolic Events: A Case-Control Study
por: Atalay, Figen, et al.
Publicado: (2014)

Double filtration plasmapheresis in a dog with multiple myeloma and hyperviscosity syndrome
por: Lippi, I., et al.
Publicado: (2015)

COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?
por: Maier, Cheryl L, et al.
Publicado: (2020)

EPOS Abstract Book
Publicado: (2022)

Welcome to EPOS 2023
por: Sanpera, Ignacio, et al.
Publicado: (2023)

EPOS Abstract Book
Publicado: (2023)

Polyclonal hyperviscosity syndrome in IgG4-related disease and associated conditions
por: Chen, Luke YC, et al.
Publicado: (2015)

The Relationship between Seminal Fluid Hyperviscosity and Oxidative Stress: A Systematic Review
por: Barbagallo, Federica, et al.
Publicado: (2021)

Incidence and impact of hyperviscosity on sperm parameters of Malawian men seeking assisted reproduction
por: Lampiao, Fanuel, et al.
Publicado: (2020)

Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19
por: Joob, Beuy, et al.
Publicado: (2021)

Multimodal Imaging of Waldenstrom Macroglobulinemia-Associated Hyperviscosity-Related Retinopathy Treated with Plasmapheresis
por: Schatz, Michael J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4u0vupbftep89dplncji3mk0pu